| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| New Era Alkaloids and Export Limited |
|
Particulars |
31-03-2024 |
31-03-2023 |
|
Non-current
assets |
|
|
|
Property,
plant and equipment |
0.04 |
0.06 |
|
Investments |
212.98 |
1180.17 |
|
Loans
and advances |
535.56 |
456.74 |
|
Deferred
tax assets (net) |
26.49 |
- |
|
Other
non-current assets |
55.27 |
55.27 |
|
Current
assets |
|
|
|
Trade
receivables |
- |
9.82 |
|
Cash
and cash equivalents |
3.99 |
3.39 |
|
Current
Tax Assets |
1.31 |
- |
|
Other
Current Assets |
27.04 |
26.99 |
|
Total
assets |
862.69 |
1733.23 |
|
Equity |
|
|
|
Equity
share capital |
328.44 |
328.44 |
|
Other
equity |
474.40 |
477.93 |
|
Non-current
liabilities |
|
|
|
Borrowings |
- |
493.61 |
|
Deferred
tax liabilities (net) |
- |
96.64 |
|
Current
liabilities |
|
|
|
Borrowings |
- |
335.00 |
|
Total outstanding dues of creditors other than micro enterprises and small
enterprises |
0.31 |
- |
|
Other
financial liabilities |
0.08 |
1.15 |
|
Current
tax liabilities (net) |
58.87 |
- |
|
Provisions |
0.60 |
0.47 |
|
Total
equity and liabilities |
862.69 |
1733.23 |
|
Particulars |
31-03-2024 |
31-03-2023 |
|
Revenue
from Operation |
- |
8.00 |
|
Other
Income |
39.38 |
8.12 |
|
Total
Income |
|
|
|
Expenses |
|
|
|
Employee
Benefits Expenses |
2.96 |
2.87 |
|
Finance
Costs |
0.01 |
0.01 |
|
Depreciation
and Amortization Expenses |
0.02 |
0.03 |
|
Other
Expenses |
3.23 |
114.32 |
|
Total
Expenses |
6.22 |
117.32 |
|
Profit/Loss
before tax |
33.17 |
-109.11 |
|
Current
tax |
58.87 |
- |
|
Deferred
tax |
0.01 |
0.01 |
|
Profit/Loss
for the Period |
-25.72 |
-109.12 |
|
Other comprehensive income |
|
|
|
Items
that will not be reclassified to profit and loss |
-100.96 |
294.59 |
|
Income tax relating to items that will not be reclassified to profit or loss |
123.14 |
-94.82 |
|
Total
comprehensive income for the year |
-3.54 |
90.65 |
|
Paid-up
Share Capital |
328.44 |
328.44 |
|
Earnings
per Equity Share |
-0.78 |
-3.32 |
|
Particulars |
31-03-2024 |
31-03-2023 |
|
Cash
Flow From Operating Activities |
|
|
|
Profit/(loss)
before tax after exceptional items |
33.17 |
-109.11 |
|
Adjustments: |
|
|
|
Depreciation
|
0.02 |
0.03 |
|
Interest
Charged to P & L A/c |
0.01 |
0.01 |
|
Interest
received from parties |
-39.35 |
- |
|
Irrecoverable
balances written off |
0.00 |
110.42 |
|
Operating
Profit before Working Capital Changes |
-6.16 |
1.35 |
|
Adjustments: |
|
|
|
Decrease/(Increase)
in Trade & Other receivables |
-69.57 |
339.61 |
|
Increase/(Decrease)
in Payables |
58.24 |
-6.30 |
|
Cash
generated from Operations |
-17.49 |
334.66 |
|
Direct
Taxes Paid |
58.87 |
- |
|
Net
Cash from Operating Activity |
-76.36 |
334.66 |
|
Cash
Flow From Investing Activities |
|
|
|
Proceeds
from sale of shares |
866.23 |
- |
|
Net
Cash from Investing Activity |
866.23 |
- |
|
Cash
Flow From Financing Activities |
|
|
|
Proceeds
from Unsecured Loans ( Net) |
-828.61 |
-334.00 |
|
Interest
Paid |
-0.01 |
-0.01 |
|
Interest
received from parties |
39.35 |
- |
|
Net
Cash From Financing Activities |
-789.27 |
-334.01 |
|
Increase
in cash and cash equivalents |
0.60 |
0.65 |
|
Cash
and cash equivalents as at the beginning of year |
3.39 |
2.74 |
|
Cash
and cash equivalents as at end of the year |
3.99 |
3.39 |
Here
is a summary of the Cash Flow Statement for the years 2024 and 2023:
Operating
Activities:
In FY 2024, the
company posted a profit before tax of ₹33.17 lakhs, recovering from a ₹109.11
lakhs loss in FY 2023. However, due to increased receivables and tax payments,
it reported a net cash
outflow of ₹76.36 lakhs, compared to an inflow of ₹334.66 lakhs
in FY 2023, which had benefited from one-time write-offs and better working
capital position.
Investing
Activities:
The company reported
a substantial inflow of
₹866.23 lakhs in FY 2024 from the sale of shares, indicating a
divestment of investments or strategic assets. This was absent in FY 2023,
where no investing activities were reported. This sharp inflow highlights a
deliberate strategy to liquidate investments to support liquidity or other
financial needs.
Financing
Activities:
In FY 2024, net outflows from financing
activities stood at ₹789.27 lakhs, primarily due to the repayment of unsecured loans
amounting to ₹828.61 lakhs. A small interest expense of ₹0.01
lakhs was recorded, and an interest
income of ₹39.35 lakhs from parties was included in this
section. In FY 2023, a
similar pattern was observed, with unsecured loans of ₹334
lakhs being repaid, resulting in a net
cash outflow of ₹334.01 lakhs. This consistent trend suggests
the company is gradually reducing its debt burden.
Net
Cash Position:
Despite negative
cash flows from operations and financing activities in FY 2024, the large investing inflow led to a
modest net increase of ₹0.60 lakhs in cash and cash equivalents,
ending the year with a closing balance of ₹3.99 lakhs, up from ₹3.39 lakhs in FY
2023. In the previous year, the net cash increase was ₹0.65 lakhs, indicating
stable but low cash reserves.
|
Particulars |
2024 |
2023 |
|
Current
ratio |
0.54 |
0.12 |
|
Debt-equity
ratio |
- |
1.03 |
|
Return
on equity ratio |
-3.20% |
-14.34% |
|
Trade
receivables turnover ratio |
- |
1.41 |
|
Net
capital turnover ratio |
- |
0.010 |
|
Net
profit ratio |
-65.30 |
-1343.13 |
|
Return
on capital employed |
4.13 |
-5.81 |
|
Operating
Profit Margin |
- |
-1365.38% |
Here is a summary of the financial and operational metrics for New Era Alkaloids & Exports Limited
Current
Ratio
A current ratio
below 1 indicates liquidity stress. Though it improved from 0.12 to 0.54 in FY
2024, the company still lacks sufficient current assets to cover its current
liabilities, raising concerns about short-term solvency.
Debt-Equity
Ratio
In FY 2023, the
company had a moderately leveraged position. The absence of the ratio in FY
2024 may indicate that either debt or equity became negative or negligible,
reflecting capital structure instability.
Return
on Equity
Negative ROE in both years
suggests the company incurred losses. However, the improvement in FY 2024 shows
reduced losses and a slight move towards recovery.
Trade
Receivables Turnover Ratio
A ratio of 1.41 in
FY 2023 indicates slow collection. The missing value in FY 2024 could mean no
significant sales or data inconsistency, impacting cash flow predictability.
Net
Capital Turnover Ratio
An extremely low value
in FY 2023 reflects poor utilization of capital. The absence of the ratio in FY
2024 might indicate negative working capital or minimal operations..
Net
Profit Ratio
Both years show net
losses, but FY 2024’s figure shows substantial improvement. However, a -65.30%
margin still signals inefficiency and high costs relative to income.
Return
on Capital Employed
A positive ROCE in
FY 2024 suggests the company is starting to generate returns from its capital,
a significant recovery from negative returns in FY 2023.
Operating Profit
Margin